The Estrogen-Induced miR-19 Downregulates Secretory Leucoprotease Inhibitor Expression in Monocytes.

Paul J. McKiernan , Stephen G.J. Smith , Andrew L. Durham , Ian M. Adcock
Journal of Innate Immunity 12 ( 1) 90 -102

2
2020
SLPI and inflammatory lung disease in females.

Paul J. McKiernan , Noel G. McElvaney , Catherine M. Greene
Biochemical Society Transactions 39 ( 5) 1421 -1426

18
2011
Loss of Microbicidal Activity and Increased Formation of Biofilm Due to Decreased Lactoferrin Activity in Patients with Cystic Fibrosis

Mark P. Rogan , Clifford C. Taggart , Catherine M. Greene , Philip G. Murphy
The Journal of Infectious Diseases 190 ( 7) 1245 -1253

132
2004
Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine

Dominik Hartl , Rabindra Tirouvanziam , Julie Laval , Catherine M. Greene
Journal of Innate Immunity 10 487 -501

37
2018
Innate Immunity of the Lung.

Catherine M. Greene , Pieter S. Hiemstra
Journal of Innate Immunity 12 ( 1) 1 -3

2
2020
Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?

Emer KELLY , Ruth E. MacREDMOND , Garret CULLEN , Catherine M. GREENE
Respirology 14 ( 2) 210 -216

26
2009
Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway

David A BERGIN , Catherine M GREENE , Erwin E STERCHI , Cliona KENNA
The Journal of biological chemistry 284 ( 14) 9624 -9624

1
2009
The Toll-like Receptor Family

Catherine M. Greene

1
2012
Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33

Wim Timens , Dirkje S. Postma , Barbro N. Melgert , Barbro N. Melgert
European Respiratory Journal 40 2358

2
2012
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology

Noel G. McElvaney , Paul J. McKiernan , Catherine M. Greene , Orla Cunningham
European Respiratory Journal 40 3723

2012
Bronchial Epithelial Cell Transcriptomics: A Tool to Monitor and Predict Chronic Obstructive Pulmonary Disease Progression?

Catherine M. Greene , Chiara De Santi
American Journal of Respiratory Cell and Molecular Biology 64 ( 4) 399 -400

2021
Protein quality control in lung disease: it’s all about cloud networking

Silke Meiners , Catherine M. Greene
European Respiratory Journal 44 ( 4) 846 -849

4
2014
Developmental control of CFTR: from bioinformatics to novel therapeutic approaches

Catherine M. Greene , Dominik Hartl
European Respiratory Journal 45 ( 1) 18 -20

3
2015
miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production

Catherine M. Greene , Irene K. Oglesby , Sebastian F. Vencken , Raman Agrawal
European Respiratory Journal 46 ( 5) 1350 -1360

41
2015
MicroRNA Dysregulation in Cystic Fibrosis

Paul J. McKiernan , Catherine M. Greene
Mediators of Inflammation 2015 529642 -529642

27
2015
Cystic fibrosis epithelial cells are primed for apoptosis as a result of increased Fas (CD95)

Qiwei Chen , Sudha Priya Soundara Pandi , Lauren Kerrigan , Noel G. McElvaney
Journal of Cystic Fibrosis 17 ( 5) 616 -623

3
2018
Neutrophil Elastase Up-Regulates Cathepsin B and Matrix Metalloprotease-2 Expression

Patrick Geraghty , Mark P. Rogan , Catherine M. Greene , Rachel M. M. Boxio
Journal of Immunology 178 ( 9) 5871 -5878

97
2007
Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases

Kevin Molloy , Stephen G. Smith , Gerard Cagney , Eugene T. Dillon
Pathogenetics 8 ( 3) 92

4
2019
α1-Antitrypsin deficiency

Catherine M. Greene , Stefan J. Marciniak , Jeffrey Teckman , Ilaria Ferrarotti
Nature Reviews Disease Primers 2 ( 1) 16051 -16051

94
2016
microRNAs in asthma: potential therapeutic targets.

Catherine M. Greene , Kevin P. Gaughan
Current Opinion in Pulmonary Medicine 19 ( 1) 66 -72

34
2013